| Oct 29 |
Why Charles River (CRL) is Poised to Beat Earnings Estimates Again
|
| Oct 25 |
P/E Ratio Insights for Charles River
|
| Oct 22 |
CRL Gears Up for Q3 Earnings: Here's What You Need to Know
|
| Oct 21 |
FibroBiologics and Charles River link for chronic disease therapies manufacture
|
| Oct 18 |
CRL Stock Gains From New Retrogenix Non-Human Protein Library Launch
|
| Oct 17 |
Charles River Launches New Retrogenix® Non-Human Protein Library
|
| Oct 16 |
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
|
| Oct 10 |
CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
|
| Oct 7 |
Charles River cut to in line by Evercore on weakening demand
|
| Oct 7 |
This Alibaba Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
|
